CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF405S conjugate, 0.1mg/mL [26628-22-8]

Biotium

CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF405S conjugate, 0.1mg/mL

9

ImmunoFluorescence

Research Use Only

Monoclonal

HuLy-m2

0.1 mg/ml

Other Conjugate

CD7

CD7 molecule

CD7 antigen (p41); GP40; LEU-9; p41 protein; T-cell antigen CD7; T-cell leukemia antigen; T-cell surface antigen Leu-9; Tp40; TP41

Mouse

IgG2a

T-cell antigen CD7

Recognizes a protein of 40 kDa, identified as CD7 (Workshop IV; Code T165). CD7 is a member of the immunoglobulin gene superfamily. Its N-terminal amino acids 1-107 are highly homologous to Ig kappa-L chains whereas the carboxyl-terminal region of the extracellular domain is proline-rich and has been postulated to form a stalk from which the Ig domain projects. CD7 is expressed on the majority of immature and mature T-lymphocytes, and T cell leukemia. It is also found on natural killer cells, a small subpopulation of normal B cells and on malignant B cells. Cross-linking surface CD7 positively modulates T cell and NK cell activity as measured by calcium fluxes, expression of adhesion molecules, cytokine secretion and proliferation. CD7 associates directly with phosphoinositol 3-kinase. CD7 ligation induces production of D-3 phosphoinositides and tyrosine phosphorylation.

Animal

Bovine, Human, Mouse

2°C to 8°C

12352203